
    
      All subjects receive a single dose of isavuconazole on Day 1 under fasting conditions.
      Subjects are confined to study center from Day -1 until Day 4 when they are discharged.
      Subjects return for outpatient visits on Days 6, 8, 11, 13 and 15.
    
  